发明名称 |
Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
摘要 |
A pharmaceutical formulation for administration by inhalation comprising a compound of formula (I), wherein R<SUB>1 </SUB>represents C<SUB>1-6 </SUB>alkyl or C<SUB>1-6 </SUB>haloalkyl; R<SUB>2 </SUB>represents -C(-O)-aryl or -C(-O)-heteroaryl; R<SUB>3 </SUB>represents hydrogen, methyl (which may be in either the alpha or beta configuration) or methylene; R<SUB>4 </SUB>and R<SUB>5 </SUB>are the same or different and each represents hydrogen or halogen; and represents a single or a double bond; and salts and solvates thereof together with a long-acting beta<SUB>2</SUB>-adrenoreceptor agonist which formulation has a therapeutically useful effect in the treatment of inflammatory disorders of the respiratory tract over a period of 24 hours or more.
|
申请公布号 |
US2005175545(A1) |
申请公布日期 |
2005.08.11 |
申请号 |
US20050503540 |
申请日期 |
2005.03.25 |
申请人 |
BIGGADIKE KEITH;JONES PAUL;PAYNE JEREMY J. |
发明人 |
BIGGADIKE KEITH;JONES PAUL;PAYNE JEREMY J. |
分类号 |
A61K9/00;A61K31/18;A61K31/573;A61K31/58;(IPC1-7):A61K9/14 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|